Minerva Neurosciences, Inc. (NERV) shareholders
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ann C. Donahue Joint filing with Federated Hermes, Inc. (19.86%), Voting Shares Irrevocable Trust (19.86%) and 2 more | 9,392,275 | 19.86% | 13G (passive) | Dec 22, 2025 |
| Federated Hermes, Inc. Joint filing with Voting Shares Irrevocable Trust (17.17%), Thomas R. Donahue (17.17%) and 2 more | 8,690,926 | 17.17% | 13G (passive) amendment | Jun 30, 2026 |
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (9.99%), Vivo Opportunity Cayman Fund, L.P. (9.99%) and 1 more | 8,591,572 | 9.99% | 13G (passive) | Dec 23, 2025 |
| Farallon Capital Management, L.L.C. Joint filing with Dapice Joshua J. (9.70%), Dreyfuss, Philip D. (9.70%) and 13 more | 4,730,000 | 9.70% | 13G (passive) amendment | Jun 30, 2026 |
| Balyasny Asset Management L.P. Joint filing with Bam Gp LLC (9.99%), Balyasny Asset Management Holdings LP (9.99%) and 2 more | 4,654,212 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Coastlands Capital LP Joint filing with Coastlands Capital Partners LP (9.99%), Coastlands Capital GP LLC (9.99%) and 2 more | 4,563,031 | 9.99% | 13G (passive) | Feb 13, 2026 |
| Giauque, Nicolas Joint filing with Wehrly, Mark C. (9.99%), Dapice Joshua J. (9.99%) and 13 more | 4,539,854 | 9.99% | 13G (passive) amendment | Dec 31, 2025 |
| Spokes, Andrew J. M. Joint filing with Wehrly, Mark C. (9.99%), Dapice Joshua J. (9.99%) and 15 more | 4,539,854 | 9.99% | 13G (passive) | Dec 22, 2025 |
| William Arsani Joint filing with Logos Global Management LP (9.90%), Logos Global Management GP LLC (9.90%) and 3 more | 4,435,444 | 9.90% | 13G (passive) | Dec 23, 2025 |
| Balyasny Asset Management Holdings LP Joint filing with Balyasny Asset Management L.P. (9.99%), Bam Gp LLC (9.99%) and 2 more | 4,323,112 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Janus Henderson Group PLC | 4,307,759 | 9.90% | 13G (passive) | Mar 31, 2026 |
| Phillip Gross Joint filing with Adage Capital Management, L.P. (6.35%), Robert Atchinson (6.35%) | 2,838,000 | 6.35% | 13G (passive) | Dec 31, 2025 |
| BlackRock, Inc. | 2,450,284 | 5.10% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NERV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 4,670,426 | 9.78% | $25.92M | −442,798 | 0.04% |
| Jupiter Topco LLC | 4,386,027 | 9.19% | $24.32M | New | 0.01% |
| Vivo Capital, LLC | 4,322,747 | 9.05% | $23.99M | – | 2.19% |
| Balyasny Asset Management L.P. | 4,257,000 | 8.92% | $23.63M | −1,600 | 0.03% |
| Logos Global Management LP | 3,288,777 | 6.89% | $18.25M | +73,777 | 0.79% |
| Farallon Capital Management LLC | 2,365,000 | 4.95% | $13.13M | – | 0.06% |
| BlackRock, Inc. | 2,240,578 | 4.69% | $12.44M | +1,615,721 | 0.00% |
| Ally Bridge Group (NY) LLC | 2,175,802 | 4.56% | $12.08M | +520,302 | 10.68% |
| Foresite Capital Management VI LLC | 1,985,584 | 4.16% | $11.02M | −1,016 | 1.71% |
| Vanguard Capital Management LLC | 1,892,807 | 3.96% | $10.51M | +46,976 | 0.00% |
| Spruce Street Capital LP | 1,655,500 | 3.47% | $9.19M | – | 1.80% |
| Trails Edge Capital Partners, LP | 1,419,000 | 2.97% | $7.88M | – | 1.25% |
| Adage Capital Partners Gp, L.L.C. | 1,419,000 | 2.97% | $7.88M | – | 0.01% |
| Seven Fleet Capital Management LP | 1,001,373 | 2.10% | $5.56M | +752,897 | 0.92% |
| Geode Capital Management, LLC | 974,236 | 2.04% | $5.41M | +635,501 | 0.00% |
| Dv Equities, LLC | 754,397 | 1.58% | $4.19M | New | 0.60% |
| Acuta Capital Partners, LLC | 709,500 | 1.49% | $3.94M | – | 2.74% |
| Millennium Management LLC | 533,602 | 1.12% | $2.96M | −174,689 | 0.00% |
| State Street Corp | 424,915 | 0.89% | $2.36M | +368,566 | 0.00% |
| Vanguard Fiduciary Trust Co | 302,604 | 0.63% | $1.68M | +38,557 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 60 | 42M | 88.6% | 24 / 15 | 9 / 8 | 10M | 2M |
| Q1 2026 | 47 | 38M | 80.2% | 18 / 8 | 8 / 3 | 17M | 2M |
| Q4 2025 | 33 | 23M | 48.3% | 14 / 8 | 4 / 5 | 21M | 0M |
| Q3 2025 | 24 | 2M | 4.1% | 5 / 3 | 4 / 2 | 0M | 0M |
| Q2 2025 | 21 | 2M | 4.1% | 3 / 4 | 5 / 4 | 0M | 0M |
| Q1 2025 | 22 | 2M | 4.1% | 3 / 4 | 4 / 3 | 0M | 0M |
| Q4 2024 | 22 | 2M | 4.4% | 4 / 3 | 4 / 3 | 0M | 0M |
| Q3 2024 | 21 | 2M | 4.4% | 3 / 4 | 4 / 2 | 0M | 0M |
| Q2 2024 | 21 | 2M | 4.4% | 0 / 4 | 6 / 0 | 0M | 0M |
| Q1 2024 | 21 | 2M | 4.4% | 2 / 8 | 3 / 1 | 0M | 0M |
| Q4 2023 | 20 | 2M | 5.1% | 2 / 3 | 4 / 2 | 0M | 0M |
| Q3 2023 | 20 | 2M | 5.0% | 2 / 6 | 5 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
48 funds held NERV in Q2 2026, 71% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NERV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,319,143 | 2.76% | $7.32M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 651,463 | 1.36% | $3.62M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 511,673 | 1.07% | $2.84M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 370,368 | 0.78% | $1.47M | 0.00% | Jul 31, 2026 |
| Federated Hermes Kaufmann Small Cap Fund | 269,435 | 0.56% | $1.07M | 0.04% | Jul 31, 2026 |
| Federated Hermes Kaufmann Fund | 225,722 | 0.47% | $898.37K | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 220,170 | 0.46% | $1.22M | 0.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 152,543 | 0.32% | $748.99K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 113,626 | 0.24% | $630.62K | 0.04% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 92,757 | 0.19% | $514.80K | 0.00% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 82,625 | 0.17% | $328.85K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 81,021 | 0.17% | $397.81K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 65,680 | 0.14% | $322.49K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 63,647 | 0.13% | $353.24K | 0.01% | Jun 30, 2026 |
| Nuveen Small Cap Blend Index Fund | 45,478 | 0.10% | $181.00K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Remy Luthringer | CEO, Director | 184,819 | 0.39% | Jun 5, 2026 |
| Anthony Aliquo | Chief Accounting Officer | 1,683 | 0.00% | Aug 20, 2026 |
| Joseph H. Reilly | Chief Operating Officer | 20,872 | 0.04% | Aug 20, 2026 |
| Frederick W. Ahlholm | SVP, CFO and Secretary | 17,518 | 0.04% | Jun 5, 2026 |
| James Joseph O'Connor | Chief Business Officer and GC | – | – | Apr 22, 2026 |
| Geoff Race | President | 51,324 | 0.11% | Dec 23, 2025 |
| Inderjit Kaul | Director | – | – | Nov 3, 2026 |
| David Kupfer | Director | 191,488 | 0.40% | Jun 5, 2026 |
| Hans Peter Hasler | Director | 10,000 | 0.02% | Jun 5, 2026 |
| Heek G. Jan Van | Director | 20,333 | 0.04% | Jun 5, 2026 |
| Fouzia Laghrissi-Thode | Director | 0 | – | Jun 5, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Remy Luthringer CEO, Director | May 2, 2023 | Sale | −3,641 | $3.76 | $13.69K | 68,994 |
| Frederick W. Ahlholm SVP, CFO and Secretary | May 1, 2023 | Sale | −3,580 | $4.48 | $16.04K | 17,518 |
| Remy Luthringer CEO, Director | May 1, 2023 | Sale | −23,753 | $3.85 | $91.45K | 72,635 |
| Geoff Race President | May 1, 2023 | Sale | −22,082 | $3.85 | $85.02K | 51,324 |
| Frederick W. Ahlholm SVP, CFO and Secretary | Apr 28, 2023 | Award | +19,843 | – | – | 21,098 |
| Remy Luthringer CEO, Director | Apr 28, 2023 | Award | +88,077 | – | – | 96,388 |
| Geoff Race President | Apr 28, 2023 | Award | +46,987 | – | – | 73,406 |
| David Kupfer Director | Dec 1, 2021 | Sale | −55,635 | $0.88 | $48.96K | 163,553 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 16, 2020 | Sale | −3,228 | $2.64 | $8.52K | 31,747 |
| Remy Luthringer CEO, Director | Dec 16, 2020 | Sale | −1,300 | $2.64 | $3.43K | 66,490 |
| Geoff Race EVP, CFO & CBO | Dec 16, 2020 | Sale | −6,190 | $2.64 | $16.34K | 211,354 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 16, 2020 | Sale | −1,845 | $2.64 | $4.87K | 10,039 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 14, 2020 | Option exercise | +8,750 | – | – | 34,975 |
| Remy Luthringer CEO, Director | Dec 14, 2020 | Option exercise | +18,750 | – | – | 67,790 |
| Geoff Race EVP, CFO & CBO | Dec 14, 2020 | Option exercise | +12,500 | – | – | 217,544 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 14, 2020 | Option exercise | +5,000 | – | – | 11,884 |
| Heek G. Jan Van Director | Sep 10, 2020 | Buy | +7,000 | $2.97 | $20.79K | 20,333 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | May 26, 2020 | Sale(10b5-1 plan) | −8,339 | $15.00 | $125.09K | 6,884 |
| Remy Luthringer CEO, Director | Dec 17, 2019 | Sale | −2,412 | $7.10 | $17.13K | 49,040 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 17, 2019 | Sale | −2,724 | $7.10 | $19.34K | 26,225 |
| Geoff Race EVP, CFO & CBO | Dec 17, 2019 | Sale | −5,826 | $7.10 | $41.36K | 205,044 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 17, 2019 | Sale | −1,557 | $7.10 | $11.05K | 15,223 |
| Remy Luthringer CEO, Director | Dec 14, 2019 | Option exercise | +18,750 | – | – | 51,452 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 14, 2019 | Option exercise | +8,750 | – | – | 28,949 |
| Geoff Race EVP, CFO & CBO | Dec 14, 2019 | Option exercise | +12,500 | – | – | 210,870 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 14, 2019 | Option exercise | +5,000 | – | – | 16,780 |
| Richard E. Russell President | Dec 12, 2019 | Sale | −3,113 | $7.42 | $23.10K | 33,770 |
| William F. Doyle Director | Jun 27, 2019 | Buy | +3,500 | $5.50 | $19.25K | 26,111 |
| Hans Peter Hasler Director | Jun 26, 2019 | Buy | +10,000 | $5.60 | $56.00K | 10,000 |
| Jeryl L. Hilleman Director | Jun 26, 2019 | Buy | +1,000 | $5.25 | $5.25K | 1,000 |
| David Kupfer Director | Jun 26, 2019 | Buy | +10,000 | $5.55 | $55.50K | 219,188 |
| Heek G. Jan Van Director | Jun 26, 2019 | Buy | +10,000 | $5.37 | $53.70K | 13,333 |
| Venture Associates IV Ltd Index 10% owner | Jun 24, 2019 | Sale | −197,000 | $6.01 | $1.18M | 3,899,189 |
| Venture Associates III Ltd Index 10% owner | Jun 20, 2019 | Sale | −33,575 | $4.34 | $145.72K | 4,096,189 |
| Venture Associates III Ltd Index 10% owner | Jun 19, 2019 | Sale | −77,243 | $4.44 | $342.96K | 4,129,764 |
| Venture Associates V. Ltd Index 10% owner | Jun 18, 2019 | Sale | −49,675 | $4.44 | $220.56K | 4,207,007 |
| Venture Associates V. Ltd Index 10% owner | Jun 17, 2019 | Sale | −56,243 | $4.45 | $250.28K | 4,256,682 |
| Venture Associates V. Ltd Index 10% owner | Jun 14, 2019 | Sale | −25,169 | $4.50 | $113.26K | 4,312,925 |
| Venture Associates V. Ltd Index 10% owner | Jun 13, 2019 | Sale | −53,298 | $4.51 | $240.37K | 4,338,094 |
| Venture Associates III Ltd Index 10% owner | Jun 12, 2019 | Sale | −26,901 | $4.57 | $122.94K | 4,391,392 |
| Venture Associates III Ltd Index 10% owner | Jun 11, 2019 | Sale | −33,150 | $4.78 | $158.46K | 4,418,293 |
| Venture Associates IV Ltd Index 10% owner | May 20, 2019 | Sale | −200 | $6.08 | $1.22K | 4,451,443 |
| Venture Associates IV Ltd Index 10% owner | May 17, 2019 | Sale | −22,718 | $6.02 | $136.76K | 4,451,643 |
| Venture Associates IV Ltd Index 10% owner | May 16, 2019 | Sale | −44,836 | $6.37 | $285.61K | 4,474,361 |
| Venture Associates IV Ltd Index 10% owner | May 15, 2019 | Sale | −53,418 | $6.64 | $354.70K | 4,519,197 |
| Venture Associates IV Ltd Index 10% owner | May 14, 2019 | Sale | −36,574 | $7.05 | $257.85K | 4,572,615 |
| William F. Doyle Director | Dec 20, 2018 | Buy | +2,000 | $6.50 | $13.00K | 22,611 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 17, 2018 | Sale | −2,728 | $7.46 | $20.35K | 20,199 |
| Remy Luthringer CEO, Director | Dec 17, 2018 | Sale | −2,604 | $7.46 | $19.43K | 32,702 |
| Geoff Race EVP, CFO & CBO | Dec 17, 2018 | Sale | −5,999 | $7.46 | $44.75K | 198,370 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 17, 2018 | Sale | −1,559 | $7.46 | $11.63K | 11,780 |
| Joseph H. Reilly SVP & Chief Operating Officer | Dec 14, 2018 | Option exercise | +8,750 | – | – | 22,927 |
| Remy Luthringer CEO, Director | Dec 14, 2018 | Option exercise | +18,750 | – | – | 35,306 |
| Geoff Race EVP, CFO & CBO | Dec 14, 2018 | Option exercise | +12,500 | – | – | 204,369 |
| Frederick W. Ahlholm SVP, Chief Accounting Officer | Dec 14, 2018 | Option exercise | +5,000 | – | – | 13,339 |
| Richard E. Russell President | Dec 12, 2018 | Sale | −3,117 | $7.96 | $24.81K | 36,883 |
| William F. Doyle Director | Dec 11, 2018 | Buy | +4,000 | $7.95 | $31.80K | 20,611 |
| William F. Doyle Director | Dec 10, 2018 | Buy | +2,000 | $8.00 | $16.00K | 16,611 |
| William F. Doyle Director | Nov 20, 2018 | Buy | +2,000 | $8.20 | $16.40K | 14,611 |
| William F. Doyle Director | Oct 11, 2018 | Buy | +600 | $10.00 | $6.00K | 12,611 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Minerva Neurosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,663 shares on Sep 17, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Mar 31, 2026 | 63,616 | $508.93K | Mar 31, 2026 | Secondary Offering/Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Mar 31, 2026 | 39,676 | $317.41K | Mar 31, 2026 | Secondary Offering/Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Mar 31, 2026 | 17,596 | $140.77K | Mar 31, 2026 | Secondary Offering/Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Mar 10, 2026 | 12,456 | $99.65K | Mar 10, 2026 | Secondary Offering/Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Mar 10, 2026 | 264,615 | $2.12M | Mar 10, 2026 | Secondary Offering/Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Mar 10, 2026 | 424,278 | $3.39M | Mar 10, 2026 | Secondary Offering/Open Market |
See a number that looks wrong?